Venous Leg Ulcer Prevention and Management: An Integrated Approach
More than 80 million Americans have vein disease, including chronic venous insufficiency (CVI). Of those 80 million, 76% will experience reoccurrence within three to five years; this means that the majority of patients who experience CVI will have to undergo costly treatments at least twice. Health care professionals should take care to follow modern best practices, which place an emphasis on prevention of reoccurrence. Using validated classification systems such as CEAP (Clinical, Etiology, Anatomic, and Pathophysiology) as well as utilizing an integrated therapy solution to manage, treat, and prevent CVI will help patients achieve best possible outcomes.
This guide is the second in a two-part series on VLU management, and provides background information on the prevalence, causes, costs, and risks of CVIs and VLUs, as well as a CVI classification system. It also discusses current best practice treatment options for prevention and management of CVI and VLUs, including BSN Medical integrated therapy solutions that remove exudate and bacteria, rebuild tissue, reduce edema with compression therapy, and prevent VLU recurrence.
Health care professionals whose patients have CVI and are at risk for or already have VLUs will find this guide a helpful resource for creating an integrated and comprehensive care plan of prevention and treatment to facilitate healing, improve compliance with care measures, and enhance overall health and mobility.
This guide covers the following topics:
This white paper is generally written for wound care providers and other health care professionals with an interest in venous leg ulcer prevention.
Sponsored by BSN Medical, an Essity Company